XEROX HOLDINGS CORP (XRX)       14  +0.16 (+1.16%)

14  +0.16 (+1.16%)

US98421M1062 - Common Stock - Premarket: 13.95 -0.05 (-0.36%)


Fundamental Rating

2

Overall XRX gets a fundamental rating of 2 out of 10. We evaluated XRX against 35 industry peers in the Technology Hardware, Storage & Peripherals industry. Both the profitability and financial health of XRX have multiple concerns. XRX is not valued too expensively and it also shows a decent growth rate.




Profitability

Profitability Rating

1

XRX has a Piotroski-F score of 5.00. This indicates an average health and profitability for XRX.
The profitability ratios for XRX are negative, so there is not much use analyzing them.

XRX has a Return On Assets of -5.26%. This is below the industry average of 4.15%.
XRX has a Profit Margin of -9.28%. This is below the industry average of 5.26%.
VS Industry

ROA (-5.26%) VS Industry: 35% outperformed.

-104.91
45.27

Profit Margin (-9.28%) VS Industry: 27% outperformed.

-1,470.75
43.08

Valuation

Valuation Rating

4

With a Forward Price/Earnings Ratio of 7.82, the valuation of XRX can be described as cheap.
With a price book ratio of 0.53, XRX is valued rather cheaply.
Compared to an average industry price book ratio of 1.21, XRX is valued rather cheaply. On top of this, XRX is cheaper than 92% of the companies listed in the same industry.

The Price/Earnings Ratio is 16.87, which indicates a correct valuation of XRX.
Compared to an average industry Price/Earning Ratio of 11.04, XRX is valued slightly more expensive.
Compared to an average industry Enterprise Value to EBITDA ratio of 7.97, XRX is valued more expensive than its industry peers.
VS Industry

Price/Earnings (16.87) VS Industry: 31% outperformed.

242.83
1.39

Price/Book (0.53) VS Industry: 92% outperformed.

108.27
0.34

Enterprise Value/ EBITDA (11.41) VS Industry: 35% outperformed.

62.51
0.37

Growth

Growth Rating

4

The Earnings Per Share is expected to grow by 26.84% on average over the next 5 years. This is a very strong growth
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
XRX shows a decrease in Revenue. In the last year, the revenue decreased by -3.47%.

The Revenue has been decreasing by -8.16% on average over the past 5 years.
XRX is expected to show a decrease in Revenue. In the coming 5 years, the Revenue will decrease by -0.27% yearly.
XRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.57%.
The earnings per share for XRX have been decreasing by -18.35% on average. This is quite bad

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-18.35% -24.22% -52.57% -30.87% 8.92% 14.38% 26.84%
Revenue-8.16% -10.02% -3.47% 0.17% 0.06% -0.03% -0.27%

Health

Health Rating

1

XRX has a Current Ratio of 1.20. This is a normal value and indicates that XRX is financially healthy and should not expect problems in meeting its short term obligations.
XRX has a Piotroski-F score of 5.00. This indicates an average health and profitability for XRX.
Compared to an average industry Current Ratio of 1.99, XRX is worse placed to pay its short term obligations than its industry peers.
XRX has a Quick Ratio of 1.20. This is a bad value and indicates that XRX is not financially healthy enough and could expect problems in meeting its short term obligations.

Compared to an average industry Quick Ratio of 1.29, XRX is worse placed to pay its short term obligations than its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.01, XRX is requires more financing than its industry peers. 89% of its industry peers have a better Debt to Equity Ratio.
XRX has an Altman-Z score of 1.26. This is a bad value and indicates that XRX is not financially healthy and even has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.15, XRX is in worse financial health than its industry peers.
VS Industry

Debt/Equity (0.68) VS Industry: 11% outperformed.

46.44
0.00

Quick Ratio (0.98) VS Industry: 35% outperformed.

0.37
36.24

Current Ratio (1.2) VS Industry: 29% outperformed.

0.48
36.70

Altman-Z (1.26) VS Industry: 36% outperformed.

-10.30
23.44

Dividend

Dividend Rating

6

With a Yearly Dividend Yield of 6.17%, XRX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.48, XRX pays a better dividend. On top of this XRX pays more dividend than 100% of the companies listed in the same industry.
XRX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.48.

XRX has paid a dividend for at least 10 years, which is a reliable track record.
XRX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
VS Industry

Dividend Yield (6.17%) VS Industry: 100% outperformed.

0.61
6.17
XRX Daily chart

XEROX HOLDINGS CORP14

NASDAQ:XRX (9/27/2022, 7:23:37 PM)+0.16 (+1.16%)

Premarket: 13.95 -0.05 (-0.36%)

Chartmill FA Rating
GICS Sector Information Technology
GICS IndustryGroup Technology Hardware & Equipment
GICS Industry Technology Hardware, Storage & Peripherals
Earnings (Last) 07-26 2022-07-26/bmo Earnings (Next) 10-24 2022-10-24
Ins Owners 0.81% Inst Owners 96.05%
Market Cap 2.18B Analysts 44
Valuation
PE 16.87 Fwd PE 7.82
PEG (NY) N/A PEG (5Y) N/A
P/S 0.31 P/B 0.53
EV/EBITDA 11.41
Dividend
Dividend Yield 6.17% Dividend Growth N/A
DP -28.84% Ex-Date 09-29 2022-09-29 (0.25)
Growth
EPS 1Y -52.57% EPS 3Y -24.22%
EPS 5Y -18.35% EPS growth Q2Q -72.34%
EPS Next Y -30.87% EPS Next 2Y 8.92%
EPS Next 3Y 14.38% EPS Next 5Y 26.84%
Revenue growth 1Y -3.47% Revenue growth 3Y -10.02%
Revenue growth 5Y -8.16% Revenue growth Q2Q -2.57%
Revenue Next Year 0.17% Revenue Next 2Y 0.06%
Revenue Next 3Y -0.03% Revenue Next 5Y -0.27%
Health
Current Ratio 1.2 Quick Ratio 0.98
Altman-Z 1.26 F-Score 5
Debt/Equity 0.68
Profitability
ROA -5.26% ROE N/A
ROIC 1.89% ROICg 1.15%
PM -9.28 OM 1.97
Asset Turnover 0.57

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA